Driehaus Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-133,187	Closed	-$2.04M	–	564
2014 Q1	$2.04M	Buy	+133,187	New	+$2.04M	0.06%	329